Johnson City’s Crown Laboratories Has Announced Updated Terms To Acquire Revance Therapeutics. Crown Will Pay 3 Dollars And 10 Cents Per Share For The Aesthetic And Therapeutic Company. The Maker Of Blue Lizard Sunscreen Says The Merger Will Create A Comprehensive Skincare And Aesthetics Portfolio. The Deal Is Expected To Close In Early 2025.
